Laurent Gapin
Concepts (335)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Natural Killer T-Cells | 23 | 2020 | 62 | 6.790 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 34 | 2021 | 311 | 5.250 |
Why?
| Thymus Gland | 19 | 2020 | 298 | 3.750 |
Why?
| T-Lymphocyte Subsets | 17 | 2024 | 393 | 3.500 |
Why?
| Killer Cells, Natural | 23 | 2018 | 380 | 3.070 |
Why?
| Antigens, CD1d | 23 | 2020 | 63 | 2.810 |
Why?
| Antigens, CD1 | 14 | 2021 | 59 | 2.740 |
Why?
| Cell Differentiation | 14 | 2020 | 1746 | 2.480 |
Why?
| T-Lymphocytes | 20 | 2021 | 1770 | 2.430 |
Why?
| Receptors, Antigen, T-Cell | 14 | 2024 | 634 | 2.060 |
Why?
| Histocompatibility Antigens Class I | 7 | 2016 | 174 | 1.420 |
Why?
| Thymocytes | 5 | 2020 | 29 | 1.230 |
Why?
| T-Cell Antigen Receptor Specificity | 6 | 2017 | 41 | 1.200 |
Why?
| Histocompatibility Antigens Class II | 10 | 2020 | 353 | 1.010 |
Why?
| Antigen Presentation | 9 | 2018 | 194 | 1.010 |
Why?
| Histocompatibility Antigens | 4 | 2019 | 102 | 1.000 |
Why?
| Glycolipids | 5 | 2018 | 37 | 0.970 |
Why?
| Autoantigens | 6 | 2020 | 397 | 0.960 |
Why?
| Animals | 76 | 2021 | 33152 | 0.920 |
Why?
| Mice, Inbred C57BL | 30 | 2020 | 4887 | 0.910 |
Why?
| Evolution, Molecular | 3 | 2019 | 454 | 0.900 |
Why?
| Mice | 62 | 2021 | 15446 | 0.890 |
Why?
| Immunity, Innate | 3 | 2020 | 744 | 0.780 |
Why?
| Single-Cell Analysis | 2 | 2021 | 186 | 0.720 |
Why?
| Galactosylceramides | 10 | 2012 | 22 | 0.710 |
Why?
| Minor Histocompatibility Antigens | 3 | 2016 | 41 | 0.710 |
Why?
| Lymphocyte Activation | 17 | 2020 | 1062 | 0.660 |
Why?
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 6 | 2012 | 21 | 0.660 |
Why?
| Flow Cytometry | 6 | 2018 | 1072 | 0.650 |
Why?
| Models, Immunological | 3 | 2007 | 92 | 0.630 |
Why?
| Demethylation | 1 | 2017 | 3 | 0.600 |
Why?
| Mice, Knockout | 16 | 2020 | 2664 | 0.590 |
Why?
| Genes, MHC Class I | 1 | 2016 | 33 | 0.560 |
Why?
| Wasp Venoms | 1 | 2016 | 4 | 0.560 |
Why?
| Bee Venoms | 1 | 2016 | 8 | 0.560 |
Why?
| Mice, Inbred BALB C | 11 | 2019 | 1202 | 0.550 |
Why?
| CD4-Positive T-Lymphocytes | 8 | 2021 | 979 | 0.540 |
Why?
| Immunity, Mucosal | 2 | 2014 | 85 | 0.540 |
Why?
| Autoimmunity | 8 | 2020 | 831 | 0.530 |
Why?
| Intestinal Mucosa | 3 | 2014 | 529 | 0.530 |
Why?
| T-Box Domain Proteins | 6 | 2007 | 95 | 0.520 |
Why?
| Cells, Cultured | 11 | 2020 | 4044 | 0.500 |
Why?
| CD8-Positive T-Lymphocytes | 9 | 2013 | 695 | 0.470 |
Why?
| Pterins | 1 | 2012 | 8 | 0.450 |
Why?
| Immunologic Memory | 7 | 2020 | 312 | 0.440 |
Why?
| Major Histocompatibility Complex | 5 | 2017 | 220 | 0.440 |
Why?
| Antigens | 8 | 2020 | 319 | 0.430 |
Why?
| Peptide Fragments | 7 | 2019 | 700 | 0.420 |
Why?
| Protein Conformation | 7 | 2018 | 848 | 0.420 |
Why?
| Hypersensitivity | 1 | 2016 | 270 | 0.420 |
Why?
| Mice, Transgenic | 10 | 2018 | 2012 | 0.410 |
Why?
| Folic Acid | 1 | 2012 | 161 | 0.410 |
Why?
| Globosides | 2 | 2011 | 2 | 0.410 |
Why?
| Self Tolerance | 1 | 2010 | 28 | 0.370 |
Why?
| Dendritic Cells | 6 | 2013 | 442 | 0.360 |
Why?
| Transcription Factors | 6 | 2016 | 1567 | 0.350 |
Why?
| Interferon-gamma | 8 | 2020 | 735 | 0.350 |
Why?
| Signal Transduction | 5 | 2020 | 4688 | 0.350 |
Why?
| CD8 Antigens | 3 | 2013 | 70 | 0.340 |
Why?
| Th1 Cells | 2 | 2007 | 132 | 0.330 |
Why?
| Escherichia coli | 1 | 2013 | 757 | 0.330 |
Why?
| Lipids | 5 | 2021 | 591 | 0.330 |
Why?
| Immune Tolerance | 3 | 2020 | 330 | 0.330 |
Why?
| Muramidase | 4 | 2002 | 72 | 0.330 |
Why?
| Lymphocyte Subsets | 2 | 2005 | 75 | 0.310 |
Why?
| Protein Binding | 9 | 2019 | 1969 | 0.310 |
Why?
| Cell Line | 7 | 2020 | 2693 | 0.300 |
Why?
| Galactosyltransferases | 1 | 2007 | 12 | 0.300 |
Why?
| Hybridomas | 6 | 2019 | 233 | 0.300 |
Why?
| Early Growth Response Protein 2 | 2 | 2018 | 11 | 0.290 |
Why?
| Antigens, Bacterial | 3 | 2017 | 116 | 0.280 |
Why?
| Genes, T-Cell Receptor alpha | 2 | 2003 | 11 | 0.280 |
Why?
| Cell Movement | 2 | 2007 | 888 | 0.270 |
Why?
| Gene Expression Profiling | 3 | 2020 | 1590 | 0.260 |
Why?
| Humans | 33 | 2024 | 118251 | 0.250 |
Why?
| Peptides | 5 | 2016 | 879 | 0.250 |
Why?
| Crystallography, X-Ray | 3 | 2018 | 421 | 0.250 |
Why?
| Immunoglobulin Variable Region | 4 | 2012 | 72 | 0.250 |
Why?
| Immunophenotyping | 4 | 2018 | 276 | 0.250 |
Why?
| Models, Molecular | 8 | 2013 | 1434 | 0.240 |
Why?
| Gene Expression Regulation | 4 | 2013 | 2435 | 0.230 |
Why?
| CD40 Antigens | 4 | 2014 | 79 | 0.230 |
Why?
| Mutation | 5 | 2019 | 3435 | 0.210 |
Why?
| Hematologic Neoplasms | 1 | 2024 | 132 | 0.210 |
Why?
| Surface Plasmon Resonance | 5 | 2013 | 85 | 0.210 |
Why?
| Amino Acid Sequence | 8 | 2019 | 2063 | 0.210 |
Why?
| Strongylida Infections | 1 | 2021 | 6 | 0.200 |
Why?
| Interleukin-4 | 4 | 2003 | 216 | 0.200 |
Why?
| Mucosal-Associated Invariant T Cells | 1 | 2020 | 14 | 0.190 |
Why?
| Syk Kinase | 1 | 2020 | 16 | 0.190 |
Why?
| Retroviridae | 2 | 2013 | 89 | 0.190 |
Why?
| H-2 Antigens | 1 | 1999 | 111 | 0.180 |
Why?
| Amino Acid Motifs | 1 | 2019 | 200 | 0.170 |
Why?
| Binding Sites | 3 | 2018 | 1221 | 0.170 |
Why?
| Immunity, Cellular | 1 | 2020 | 268 | 0.170 |
Why?
| Respiratory Hypersensitivity | 2 | 2010 | 65 | 0.170 |
Why?
| Immune System | 2 | 2013 | 181 | 0.160 |
Why?
| Cell Line, Transformed | 1 | 2018 | 135 | 0.160 |
Why?
| Sequence Analysis, RNA | 1 | 2020 | 410 | 0.160 |
Why?
| Immunodominant Epitopes | 1 | 1998 | 27 | 0.160 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 1 | 2020 | 191 | 0.160 |
Why?
| NFATC Transcription Factors | 1 | 2018 | 82 | 0.160 |
Why?
| Complementarity Determining Regions | 5 | 2012 | 45 | 0.160 |
Why?
| Mycolic Acids | 1 | 2017 | 6 | 0.160 |
Why?
| Selection, Genetic | 1 | 2019 | 252 | 0.150 |
Why?
| Cell Wall | 1 | 2017 | 53 | 0.150 |
Why?
| Mutagenesis | 3 | 2013 | 176 | 0.150 |
Why?
| Histone Demethylases | 1 | 2017 | 28 | 0.150 |
Why?
| Viral Vaccines | 1 | 1998 | 89 | 0.150 |
Why?
| Interleukin-15 | 3 | 2013 | 77 | 0.140 |
Why?
| Protein Isoforms | 1 | 2018 | 345 | 0.140 |
Why?
| Transcription Activator-Like Effector Nucleases | 1 | 2016 | 6 | 0.140 |
Why?
| Skin | 1 | 2021 | 657 | 0.140 |
Why?
| Cell Lineage | 2 | 2013 | 316 | 0.140 |
Why?
| Staphylococcal Infections | 1 | 2020 | 348 | 0.140 |
Why?
| Ovalbumin | 3 | 2014 | 165 | 0.140 |
Why?
| Lymph Nodes | 2 | 2021 | 443 | 0.140 |
Why?
| Alleles | 2 | 2017 | 829 | 0.140 |
Why?
| Insulin | 2 | 2019 | 2157 | 0.140 |
Why?
| Latent Tuberculosis | 1 | 2016 | 69 | 0.130 |
Why?
| Coculture Techniques | 2 | 2013 | 206 | 0.130 |
Why?
| Tissue Distribution | 1 | 2016 | 332 | 0.130 |
Why?
| Amino Acids | 2 | 2009 | 462 | 0.130 |
Why?
| Receptors, Natural Killer Cell | 2 | 2011 | 16 | 0.120 |
Why?
| Cytokines | 4 | 2020 | 1880 | 0.120 |
Why?
| Adoptive Transfer | 4 | 2020 | 203 | 0.120 |
Why?
| Mycobacterium tuberculosis | 1 | 2017 | 266 | 0.120 |
Why?
| Bacterial Vaccines | 1 | 2014 | 60 | 0.120 |
Why?
| Germ Cells | 2 | 2016 | 64 | 0.120 |
Why?
| DNA-Binding Proteins | 1 | 2020 | 1343 | 0.120 |
Why?
| Endopeptidase K | 1 | 2013 | 14 | 0.110 |
Why?
| Adaptive Immunity | 1 | 2014 | 160 | 0.110 |
Why?
| Sulfoglycosphingolipids | 1 | 2012 | 3 | 0.110 |
Why?
| Interleukins | 1 | 2014 | 242 | 0.110 |
Why?
| Polymerase Chain Reaction | 3 | 2012 | 1004 | 0.110 |
Why?
| Proteolysis | 1 | 2013 | 146 | 0.110 |
Why?
| Epitopes | 2 | 2011 | 439 | 0.110 |
Why?
| CD40 Ligand | 1 | 2012 | 44 | 0.100 |
Why?
| B-Lymphocytes | 2 | 2013 | 767 | 0.100 |
Why?
| Burkitt Lymphoma | 1 | 2012 | 53 | 0.100 |
Why?
| Cell Proliferation | 5 | 2020 | 2262 | 0.100 |
Why?
| Interleukin-2 Receptor beta Subunit | 2 | 2013 | 20 | 0.100 |
Why?
| Trihexosylceramides | 1 | 2011 | 5 | 0.100 |
Why?
| Histones | 1 | 2017 | 546 | 0.100 |
Why?
| Promoter Regions, Genetic | 2 | 2013 | 1157 | 0.100 |
Why?
| Th2 Cells | 2 | 2003 | 164 | 0.090 |
Why?
| Immunoglobulin Joining Region | 2 | 2001 | 10 | 0.090 |
Why?
| CD27 Ligand | 1 | 2009 | 9 | 0.090 |
Why?
| Molecular Sequence Data | 6 | 2011 | 2855 | 0.090 |
Why?
| Neoplasms | 1 | 2024 | 2160 | 0.090 |
Why?
| Multiprotein Complexes | 1 | 2011 | 148 | 0.090 |
Why?
| Lipid Metabolism | 1 | 2013 | 473 | 0.090 |
Why?
| Epitopes, T-Lymphocyte | 3 | 2019 | 170 | 0.090 |
Why?
| Biomarkers | 2 | 2018 | 3567 | 0.080 |
Why?
| In Vitro Techniques | 1 | 2011 | 1082 | 0.080 |
Why?
| Mice, Inbred NOD | 3 | 2019 | 572 | 0.080 |
Why?
| Colitis | 2 | 2002 | 219 | 0.080 |
Why?
| Immunization | 3 | 2013 | 412 | 0.080 |
Why?
| Cytotoxicity, Immunologic | 1 | 2008 | 197 | 0.080 |
Why?
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2007 | 11 | 0.080 |
Why?
| Crystallography | 1 | 2007 | 25 | 0.080 |
Why?
| Proto-Oncogene Proteins c-fyn | 1 | 2007 | 12 | 0.080 |
Why?
| Receptors, Thyroid Hormone | 1 | 2007 | 20 | 0.080 |
Why?
| Receptors, Retinoic Acid | 1 | 2007 | 40 | 0.080 |
Why?
| Adjuvants, Immunologic | 2 | 2014 | 207 | 0.080 |
Why?
| Receptors, CXCR3 | 1 | 2007 | 15 | 0.080 |
Why?
| Receptors, Chemokine | 1 | 2007 | 45 | 0.070 |
Why?
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2007 | 102 | 0.070 |
Why?
| Estrogen Antagonists | 1 | 2007 | 39 | 0.070 |
Why?
| Clone Cells | 3 | 2017 | 247 | 0.070 |
Why?
| RNA, Messenger | 3 | 2003 | 2657 | 0.070 |
Why?
| Allergens | 1 | 2010 | 425 | 0.070 |
Why?
| Vaccination | 1 | 2014 | 1218 | 0.070 |
Why?
| Tamoxifen | 1 | 2007 | 198 | 0.070 |
Why?
| Time Factors | 2 | 2013 | 6368 | 0.070 |
Why?
| Female | 10 | 2020 | 61261 | 0.070 |
Why?
| Cross Reactions | 2 | 2017 | 116 | 0.070 |
Why?
| Interleukin-12 | 2 | 2020 | 110 | 0.060 |
Why?
| T-Lymphocytes, Cytotoxic | 2 | 2012 | 159 | 0.060 |
Why?
| Diabetes Mellitus, Type 1 | 2 | 2019 | 3358 | 0.060 |
Why?
| Transcription, Genetic | 3 | 2020 | 1322 | 0.060 |
Why?
| Receptors, Estrogen | 1 | 2007 | 386 | 0.060 |
Why?
| Inflammation | 2 | 2020 | 2545 | 0.060 |
Why?
| Cell Survival | 1 | 2005 | 1045 | 0.050 |
Why?
| Structure-Activity Relationship | 3 | 2011 | 522 | 0.050 |
Why?
| Nippostrongylus | 1 | 2021 | 3 | 0.050 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 394 | 0.050 |
Why?
| Bacterial Load | 1 | 2020 | 61 | 0.050 |
Why?
| Tumor Microenvironment | 1 | 2024 | 453 | 0.050 |
Why?
| Crystallization | 2 | 2012 | 146 | 0.050 |
Why?
| Myeloid Differentiation Factor 88 | 1 | 2020 | 95 | 0.050 |
Why?
| Receptors, Interleukin | 2 | 2014 | 40 | 0.050 |
Why?
| Colon | 1 | 2002 | 237 | 0.050 |
Why?
| Histocompatibility Antigen H-2D | 1 | 1999 | 21 | 0.050 |
Why?
| Interleukin-10 | 1 | 2002 | 304 | 0.040 |
Why?
| Lymphopenia | 1 | 1999 | 48 | 0.040 |
Why?
| Immunotherapy | 1 | 2024 | 493 | 0.040 |
Why?
| Spleen | 2 | 2000 | 504 | 0.040 |
Why?
| Cloning, Molecular | 2 | 2011 | 541 | 0.040 |
Why?
| DNA Repair | 1 | 2020 | 197 | 0.040 |
Why?
| Mice, Inbred Strains | 1 | 1999 | 404 | 0.040 |
Why?
| Molecular Docking Simulation | 1 | 2019 | 101 | 0.040 |
Why?
| Gene Rearrangement, T-Lymphocyte | 1 | 1998 | 13 | 0.040 |
Why?
| Lysosomes | 1 | 2019 | 135 | 0.040 |
Why?
| HLA-DQ Antigens | 1 | 2019 | 176 | 0.040 |
Why?
| CD3 Complex | 1 | 2018 | 93 | 0.040 |
Why?
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 1998 | 26 | 0.040 |
Why?
| Antigen-Antibody Reactions | 1 | 1998 | 50 | 0.040 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2012 | 2159 | 0.040 |
Why?
| Cytotoxicity Tests, Immunologic | 1 | 1998 | 49 | 0.040 |
Why?
| Male | 4 | 2020 | 57474 | 0.040 |
Why?
| Ligands | 2 | 2010 | 565 | 0.040 |
Why?
| Receptors, IgG | 1 | 1998 | 67 | 0.040 |
Why?
| Protein Domains | 1 | 2019 | 212 | 0.040 |
Why?
| Cell Cycle | 1 | 2020 | 547 | 0.040 |
Why?
| Host-Pathogen Interactions | 1 | 2020 | 299 | 0.040 |
Why?
| Immunologic Techniques | 1 | 2017 | 40 | 0.040 |
Why?
| Chickens | 1 | 1998 | 184 | 0.040 |
Why?
| Mycobacterium phlei | 1 | 2016 | 1 | 0.040 |
Why?
| Rhodococcus equi | 1 | 2016 | 1 | 0.040 |
Why?
| Mice, Mutant Strains | 2 | 2007 | 279 | 0.040 |
Why?
| Stem Cells | 1 | 2001 | 556 | 0.040 |
Why?
| Substrate Specificity | 1 | 2017 | 369 | 0.040 |
Why?
| Phenotype | 2 | 2020 | 2937 | 0.040 |
Why?
| Pancreas | 1 | 2019 | 281 | 0.040 |
Why?
| Mice, SCID | 2 | 2012 | 331 | 0.040 |
Why?
| Bone Marrow Cells | 2 | 2010 | 273 | 0.030 |
Why?
| Radiation Chimera | 1 | 2014 | 31 | 0.030 |
Why?
| Aging | 2 | 2002 | 1675 | 0.030 |
Why?
| Vaccinia | 1 | 2014 | 19 | 0.030 |
Why?
| Smallpox Vaccine | 1 | 2014 | 23 | 0.030 |
Why?
| Receptors, Cytokine | 1 | 2014 | 33 | 0.030 |
Why?
| STAT Transcription Factors | 1 | 2014 | 15 | 0.030 |
Why?
| Poly I-C | 1 | 2014 | 55 | 0.030 |
Why?
| Transcriptome | 1 | 2020 | 752 | 0.030 |
Why?
| Lectins, C-Type | 2 | 2007 | 62 | 0.030 |
Why?
| Vaccines, Subunit | 1 | 2014 | 42 | 0.030 |
Why?
| Listeriosis | 1 | 2014 | 60 | 0.030 |
Why?
| Disease Models, Animal | 2 | 2020 | 3676 | 0.030 |
Why?
| Base Sequence | 1 | 1998 | 2148 | 0.030 |
Why?
| Toll-Like Receptors | 1 | 2014 | 167 | 0.030 |
Why?
| Alanine | 2 | 2008 | 102 | 0.030 |
Why?
| T-Lymphocytes, Regulatory | 1 | 2016 | 357 | 0.030 |
Why?
| Case-Control Studies | 1 | 2020 | 3156 | 0.030 |
Why?
| Clinical Trials as Topic | 1 | 1998 | 964 | 0.030 |
Why?
| Transplantation Chimera | 1 | 2013 | 51 | 0.030 |
Why?
| Whole-Body Irradiation | 1 | 2013 | 72 | 0.030 |
Why?
| Protein Structure, Quaternary | 1 | 2012 | 115 | 0.030 |
Why?
| Vaccines, Synthetic | 1 | 2012 | 125 | 0.030 |
Why?
| Specific Pathogen-Free Organisms | 1 | 2012 | 61 | 0.030 |
Why?
| Neoplasm Transplantation | 1 | 2012 | 245 | 0.030 |
Why?
| Cell Line, Tumor | 1 | 2019 | 2837 | 0.030 |
Why?
| Oligopeptides | 1 | 1993 | 250 | 0.030 |
Why?
| Transduction, Genetic | 1 | 2012 | 116 | 0.030 |
Why?
| Molecular Mimicry | 1 | 2011 | 40 | 0.030 |
Why?
| Tumor Burden | 1 | 2012 | 275 | 0.020 |
Why?
| Carbohydrate Sequence | 1 | 2011 | 23 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 980 | 0.020 |
Why?
| Germ-Line Mutation | 1 | 2012 | 134 | 0.020 |
Why?
| Antigens, Neoplasm | 1 | 2012 | 228 | 0.020 |
Why?
| Protein Engineering | 1 | 2011 | 107 | 0.020 |
Why?
| Thermodynamics | 2 | 2008 | 391 | 0.020 |
Why?
| Microscopy, Fluorescence | 1 | 2012 | 410 | 0.020 |
Why?
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2009 | 5 | 0.020 |
Why?
| Bronchial Hyperreactivity | 1 | 2010 | 95 | 0.020 |
Why?
| Adaptation, Biological | 1 | 2009 | 57 | 0.020 |
Why?
| Chimera | 1 | 2009 | 59 | 0.020 |
Why?
| Graft Rejection | 1 | 2012 | 548 | 0.020 |
Why?
| Listeria monocytogenes | 1 | 2009 | 110 | 0.020 |
Why?
| Lung | 1 | 2021 | 3623 | 0.020 |
Why?
| Precursor Cells, T-Lymphoid | 1 | 2008 | 1 | 0.020 |
Why?
| Intubation, Intratracheal | 1 | 2010 | 225 | 0.020 |
Why?
| Kinetics | 1 | 2011 | 1623 | 0.020 |
Why?
| Receptors, Interleukin-7 | 1 | 2007 | 26 | 0.020 |
Why?
| Bone Marrow | 1 | 2009 | 252 | 0.020 |
Why?
| Gene Expression | 1 | 2013 | 1482 | 0.020 |
Why?
| Sequence Alignment | 1 | 2008 | 334 | 0.020 |
Why?
| Amino Acid Substitution | 1 | 2008 | 275 | 0.020 |
Why?
| Protein Structure, Secondary | 1 | 2008 | 338 | 0.020 |
Why?
| Inflammation Mediators | 1 | 2010 | 497 | 0.020 |
Why?
| Models, Biological | 1 | 1994 | 1701 | 0.020 |
Why?
| Species Specificity | 1 | 2008 | 559 | 0.020 |
Why?
| Receptors, Immunologic | 1 | 2007 | 206 | 0.020 |
Why?
| Receptors, Interleukin-2 | 1 | 2005 | 65 | 0.020 |
Why?
| Amidohydrolases | 1 | 2004 | 29 | 0.020 |
Why?
| GPI-Linked Proteins | 1 | 2004 | 56 | 0.020 |
Why?
| Precipitin Tests | 1 | 2004 | 94 | 0.020 |
Why?
| CpG Islands | 1 | 2004 | 119 | 0.010 |
Why?
| Receptors, Interleukin-12 | 1 | 2003 | 6 | 0.010 |
Why?
| Cell Adhesion Molecules | 1 | 2004 | 177 | 0.010 |
Why?
| Crosses, Genetic | 1 | 2003 | 138 | 0.010 |
Why?
| Fluorescence | 1 | 2003 | 159 | 0.010 |
Why?
| Organ Culture Techniques | 1 | 2003 | 149 | 0.010 |
Why?
| Stromal Cells | 1 | 2003 | 100 | 0.010 |
Why?
| Cloning, Organism | 1 | 2002 | 6 | 0.010 |
Why?
| Phosphoproteins | 1 | 2004 | 303 | 0.010 |
Why?
| Aged | 1 | 2020 | 19594 | 0.010 |
Why?
| Freund's Adjuvant | 1 | 2002 | 17 | 0.010 |
Why?
| Aluminum Hydroxide | 1 | 2002 | 12 | 0.010 |
Why?
| Liver | 1 | 2010 | 1803 | 0.010 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 764 | 0.010 |
Why?
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2000 | 10 | 0.010 |
Why?
| Hematopoietic Stem Cells | 1 | 2004 | 359 | 0.010 |
Why?
| Antigens, Ly | 1 | 2000 | 45 | 0.010 |
Why?
| Homeostasis | 1 | 2004 | 589 | 0.010 |
Why?
| Middle Aged | 1 | 2020 | 27510 | 0.010 |
Why?
| Intestine, Large | 1 | 2000 | 15 | 0.010 |
Why?
| Genes, T-Cell Receptor beta | 1 | 2000 | 19 | 0.010 |
Why?
| Antigens, Surface | 1 | 2000 | 156 | 0.010 |
Why?
| Dimerization | 1 | 2000 | 183 | 0.010 |
Why?
| Carrier Proteins | 1 | 2004 | 725 | 0.010 |
Why?
| Leukocyte Common Antigens | 1 | 2000 | 76 | 0.010 |
Why?
| Clonal Anergy | 1 | 2000 | 54 | 0.010 |
Why?
| Chromatin | 1 | 2003 | 439 | 0.010 |
Why?
| CD4 Antigens | 1 | 2000 | 126 | 0.010 |
Why?
| Lymphocyte Depletion | 1 | 2000 | 116 | 0.010 |
Why?
| Animals, Newborn | 1 | 2002 | 804 | 0.010 |
Why?
| Adult | 1 | 2020 | 31324 | 0.010 |
Why?
| Membrane Proteins | 1 | 2004 | 1048 | 0.010 |
Why?
| Leucine | 1 | 1998 | 117 | 0.010 |
Why?
| Epithelial Cells | 1 | 2003 | 951 | 0.010 |
Why?
| Point Mutation | 1 | 1998 | 227 | 0.010 |
Why?
| Vaccines | 1 | 2002 | 380 | 0.010 |
Why?
| Tumor Cells, Cultured | 1 | 1998 | 871 | 0.010 |
Why?
| Antigens, CD | 1 | 1998 | 457 | 0.010 |
Why?
| Endopeptidases | 1 | 1994 | 71 | 0.010 |
Why?
| Binding, Competitive | 1 | 1994 | 204 | 0.010 |
Why?
| Proteins | 1 | 2000 | 935 | 0.010 |
Why?
| Dansyl Compounds | 1 | 1993 | 6 | 0.010 |
Why?
| Plasmodium berghei | 1 | 1993 | 7 | 0.010 |
Why?
| Organelles | 1 | 1994 | 55 | 0.010 |
Why?
| Endocytosis | 1 | 1994 | 152 | 0.010 |
Why?
| Macromolecular Substances | 1 | 1993 | 202 | 0.010 |
Why?
| Hydrogen-Ion Concentration | 1 | 1993 | 528 | 0.010 |
Why?
| Recombinant Proteins | 1 | 1993 | 1302 | 0.010 |
Why?
|
|
Gapin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|